JPH046349B2 - - Google Patents
Info
- Publication number
- JPH046349B2 JPH046349B2 JP59028225A JP2822584A JPH046349B2 JP H046349 B2 JPH046349 B2 JP H046349B2 JP 59028225 A JP59028225 A JP 59028225A JP 2822584 A JP2822584 A JP 2822584A JP H046349 B2 JPH046349 B2 JP H046349B2
- Authority
- JP
- Japan
- Prior art keywords
- cells
- bacteria
- bifidobacterium
- dried
- drying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241000186000 Bifidobacterium Species 0.000 claims description 20
- 239000003381 stabilizer Substances 0.000 claims description 14
- 238000004108 freeze drying Methods 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 230000000087 stabilizing effect Effects 0.000 claims description 5
- 210000004027 cell Anatomy 0.000 description 28
- 241000894006 Bacteria Species 0.000 description 20
- 230000001580 bacterial effect Effects 0.000 description 18
- 239000000243 solution Substances 0.000 description 14
- 238000001035 drying Methods 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 235000020183 skimmed milk Nutrition 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 4
- 239000004375 Dextrin Substances 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 3
- 235000013923 monosodium glutamate Nutrition 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000005001 laminate film Substances 0.000 description 2
- 238000010979 pH adjustment Methods 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 229940073490 sodium glutamate Drugs 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- QIJRTFXNRTXDIP-UHFFFAOYSA-N (1-carboxy-2-sulfanylethyl)azanium;chloride;hydrate Chemical compound O.Cl.SCC(N)C(O)=O QIJRTFXNRTXDIP-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241001608472 Bifidobacterium longum Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000009102 absorption Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229940009291 bifidobacterium longum Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 229960001305 cysteine hydrochloride Drugs 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000004223 monosodium glutamate Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- -1 seratin Proteins 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Landscapes
- Dairy Products (AREA)
- Seeds, Soups, And Other Foods (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
本発明はビフイズス乾燥菌体の安定化方法に関
する。
本発明はビフイズス菌および安定剤含有溶液の
PHを7〜10に調整し、凍結乾燥することを特徴と
するビフイズス乾燥菌体の安定化方法に関する。
ビフイズス菌は蛋白質、ビタミンの合成、消
化、吸収の補助、外来菌の増殖防止、免疫機能の
刺激等の生理機能を有し、人の健康に深いかかわ
り合いがあると言われ、人の健康増進、整腸作
用、抗生物質投与による菌交代症に治療等を目的
として食品、医薬品に使用されている。
ビフイズス菌は加工工程中の熱、圧力に弱く
又、水溶液中では、酸性、光、酸素の存在下で非
常に不安定である。長期間生菌状態を維持するた
めに、菌体は乾燥して保存され、乾燥法として凍
結真空乾燥法が採用されている。
一般に、微生物を凍結したり、乾燥したりする
と細胞形態の変化、細胞膜の選択透過性、代謝の
異常を引起こし、栄養要求の複雑は、PH、温度感
受性の高い損傷菌が生成する。乾燥菌体中にこの
ような損傷菌が多くなると、保存中の生残菌数の
低下が速くなる。これらの損傷菌を極力減らすた
めに種々の工夫がなされている。たとえば、菌体
の培養令、菌濃度、安定剤及び賦形剤の種類及び
濃度、凍結乾燥条件等について多数の報告があ
る。
常に、優れたビフイズス菌の安定化方法が求め
られている。ビフイズス菌の安定化方法について
種々検討した結果、ビフイズス菌含有液に安定化
剤を加え、PHを7〜10に調整した後、凍結乾燥す
ることにより安定化されたビフイズス乾燥菌体が
得られることが見い出された。
以下に本発明を詳細に説明する。
本発明に使用するビフイズス菌としては、ビフ
イドバクテリウム属に属する菌株であればいずれ
も用いられる。具体的にはビフイドバクテリウ
ム・インフアンテスATCC15697、ビフイドバク
テリウム・ロンガムATCC15707が用いられ、こ
れらの菌株は常法によつて、培養・濃縮される。
例えば、脱脂乳、イーストエキス、ペプトン、
グルコース、システイン塩酸塩、リン酸塩等を含
む混合培地で本菌を嫌気培養し、培養終了後直ち
に遠心分離して菌体を集菌する。該集菌体に殺菌
水を加え懸濁させて再度遠心分離を行い水洗菌体
を得る。
安定剤としては、アミノ酸類(グルタミン酸、
アスパラギン酸、リジン、アルギニン等)、糖類
(ブドウ糖、乳糖、砂糖、ソルビトール、ラフイ
ノース等)、高分子物質又はその分解物(アルブ
ミン、セラチン、ムチン、ペプトン、肉エキス、
可溶性澱粉、デキストリン、アルギン酸、ペクチ
ン、アラビアゴム等)、その他(脱脂乳、ビタミ
ンC)が用いられる。
安定剤の量としては、乾燥前の菌体液に対して
1〜50%使用される。
ビフイズス菌及び安定剤含有溶液のPHとして
は、7〜10、好ましくは8〜9.5である。
PH調整剤としては、水酸化ナトリウム、水酸化
カリウム等が用いられる。
凍結乾燥は、棚温30℃以下(品質が30℃以上に
ならないようにする)真空度0.1Torr前後で行
う。
次に、PH変化によるビフイズス乾燥菌体の保存
安定性について説明する。
常法により、ビフイドバクテリウム・インフア
ンテスATCC15697又はビフイドバクテリウム・
ロンガムATCC15707をそれぞれ嫌気培養し、水
洗、濃縮した生菌液と脱脂乳、デキストリン、グ
ルタミン酸ソーダを溶解し、PHを調整した安定剤
溶液と混合して凍結乾燥した。該乾燥菌体を防湿
性フイルムに充填し、45℃で10日及び30日保存後
の生残菌数の変化を第1(ビフイドバクテリウ
ム・インフアンテスATCC15697)及び2表(ビ
フイドバクテリウム・ロンガムATCC15707)に
それぞれ示す。
The present invention relates to a method for stabilizing dried Bifidus cells. The present invention utilizes a solution containing Bifidobacterium and a stabilizer.
The present invention relates to a method for stabilizing dried bifidus cells, which comprises adjusting the pH to 7 to 10 and freeze-drying the cells. Bifidobacterium has physiological functions such as assisting in the synthesis, digestion, and absorption of proteins and vitamins, preventing the growth of foreign bacteria, and stimulating immune function, and is said to be closely related to human health. It is used in foods and medicines for the purpose of regulating the intestines and treating bacterial replacement caused by antibiotic administration. Bifidobacterium is sensitive to heat and pressure during processing steps, and is extremely unstable in aqueous solutions in the presence of acidity, light, and oxygen. In order to maintain a viable bacterial state for a long period of time, bacterial cells are dried and stored, and freeze-vacuum drying is used as the drying method. In general, freezing or drying microorganisms causes changes in cell morphology, permselectivity of cell membranes, abnormalities in metabolism, and complex nutritional requirements, pH, and temperature-sensitive damaged bacteria are produced. When the number of such damaged bacteria increases in the dried bacterial cells, the number of surviving bacteria decreases rapidly during storage. Various efforts have been made to reduce these damaging bacteria as much as possible. For example, there are many reports regarding the culture age of bacterial cells, bacterial concentration, types and concentrations of stabilizers and excipients, freeze-drying conditions, etc. There is always a need for superior methods for stabilizing Bifidobacterium. As a result of various studies on methods for stabilizing Bifidobacterium, we found that stabilized dried Bifidobacteria cells can be obtained by adding a stabilizer to a solution containing Bifidobacteria, adjusting the pH to 7 to 10, and then freeze-drying. was discovered. The present invention will be explained in detail below. As the Bifidobacterium used in the present invention, any strain belonging to the genus Bifidobacterium can be used. Specifically, Bifidobacterium infantes ATCC 15697 and Bifidobacterium longum ATCC 15707 are used, and these strains are cultured and concentrated by conventional methods. For example, skim milk, yeast extract, peptone,
This bacterium is cultured anaerobically in a mixed medium containing glucose, cysteine hydrochloride, phosphate, etc., and immediately after the culture is completed, the bacteria are collected by centrifugation. Sterilized water is added to the collected bacterial cells to suspend them, and centrifugation is performed again to obtain washed bacterial cells. As stabilizers, amino acids (glutamic acid,
aspartic acid, lysine, arginine, etc.), sugars (glucose, lactose, sugar, sorbitol, raffinose, etc.), polymeric substances or their decomposition products (albumin, seratin, mucin, peptone, meat extract,
soluble starch, dextrin, alginic acid, pectin, gum arabic, etc.), and others (skimmed milk, vitamin C). The amount of stabilizer used is 1 to 50% of the bacterial cell fluid before drying. The pH of the solution containing Bifidobacterium and the stabilizer is 7 to 10, preferably 8 to 9.5. As the PH adjuster, sodium hydroxide, potassium hydroxide, etc. are used. Freeze-drying is performed at a shelf temperature of 30°C or lower (the quality should not exceed 30°C) and a vacuum level of around 0.1 Torr. Next, the storage stability of dried Bifidus cells due to pH changes will be explained. Bifidobacterium infantes ATCC15697 or Bifidobacterium infantes by conventional methods.
Longum ATCC15707 was cultured anaerobically, washed with water, and the concentrated viable bacterial solution was dissolved in skim milk, dextrin, and sodium glutamate, mixed with a pH-adjusted stabilizer solution, and freeze-dried. The dried bacterial cells were packed into a moisture-proof film, and the changes in the number of surviving bacteria after storage at 45°C for 10 and 30 days were measured in Tables 1 (Bifidobacterium infantes ATCC 15697) and 2 (Bifidobacterium infantes).・Longham ATCC15707).
【表】【table】
【表】【table】
【表】
第1および2表から明らかな如く、PHをアルカ
リ性にして乾燥した菌体の保存性が顕著に改良さ
れている。
以下に、実施例を示す。
実施例 1
ビフイズス菌濃縮液の調製法
ビフイドバクテリウム・インフアンテス
ATCC15697を脱脂乳を含む混合培地中で37℃、
18時間炭酸ガスを吹込みながら培養した。得られ
た培養物を水洗、遠心分離を行い、ビフイズス生
菌数4×1011コ/mlの濃縮液を得た。
安定剤溶液の調製法
40%脱脂粉乳、40%デキストリン、10%グルタ
ミン酸ソーダを含む安定剤溶液のPHは6.4であつ
た。この安定剤溶液に10%水酸化ナトリウム溶液
を加えPH8.0のアルカリ性にした。
この安定剤溶液200mlに前記ビフイズス菌濃縮
液100mlを加え混合し、−30℃で凍結し、棚温30℃
真空度0.07Torr、で18時間乾燥した。乾燥菌体
の乾燥減量(70℃、16時間真空乾燥)は1.5%、
生菌数2×1011コ/gであり菌体得量は200gであ
つた。PH未調整(6.4)の乾燥菌体の生菌数、乾
燥減量も全く同じであつた。
これら乾燥菌体1gをアルミラミネートフイル
ムに充填し45℃、1ケ月保存後のビフイズス生菌
数はPH未調整菌体で6.5×108コ/g、PH8.0調整菌
体で5.0×1010コ/gであつた。
実施例 2
実施例1において、ビフイドバクテリウム・イ
ンフアンテスATCC15697の代わりにビフイドバ
クテリウム・ロンガムATCC15707を用いる以外
は実施例1と同様にして、ビフイズス菌濃縮液
(生菌数1.5×1011コ/ml)を得た。
一方、20%脱脂粉乳、2%可溶性澱粉、2%の
グルタミン酸ソーダを含む安定剤溶液を調製し
た。この溶液のPHは6.6であつた。次に15%水酸
化カリウム溶液で安定剤溶液のPHを9.0に調整し
た該安定剤溶液200mlに前記ビフイズス菌溶液100
mlを加え、混合し実施例のようにして凍結乾燥し
た。
乾燥減量1.60%、生菌数2×1011コ/gの乾燥
菌体55gが得られた。PH未調整の乾燥菌体の乾燥
減量は1.50%、生菌数は1.5×1011コ/gであつた。
これらの乾燥菌体1gをアルミラミネートフイル
ムに充填し、45℃、1ケ月保存後の生残菌数は、
PH未調整菌体で1.5×108コ/g、PH9.0調整菌体で
4.5×1010コ/gであつた。[Table] As is clear from Tables 1 and 2, the storage stability of dried bacterial cells with an alkaline pH was significantly improved. Examples are shown below. Example 1 Preparation method of Bifidobacterium concentrate Bifidobacterium infantes
ATCC15697 was incubated at 37°C in a mixed medium containing skim milk.
Culture was carried out for 18 hours while blowing carbon dioxide gas. The obtained culture was washed with water and centrifuged to obtain a concentrated solution containing 4×10 11 viable Bifidus cells/ml. Preparation method of stabilizer solution The pH of the stabilizer solution containing 40% skim milk powder, 40% dextrin, and 10% monosodium glutamate was 6.4. A 10% sodium hydroxide solution was added to this stabilizer solution to make it alkaline to pH 8.0. Add 100 ml of the Bifidobacteria concentrate to 200 ml of this stabilizer solution, mix, freeze at -30°C, and keep the shelf temperature at 30°C.
It was dried for 18 hours at a vacuum degree of 0.07 Torr. Drying loss of dried bacterial cells (vacuum drying at 70℃ for 16 hours) is 1.5%.
The number of viable bacteria was 2×10 11 cells/g, and the amount of bacteria obtained was 200 g. The number of viable bacteria and loss on drying of dried bacterial cells without pH adjustment (6.4) were also exactly the same. After filling 1 g of these dried bacteria into an aluminum laminate film and storing it at 45℃ for 1 month, the number of viable Bifidus bacteria is 6.5 x 10 8 cells/g for PH-unadjusted bacteria and 5.0 x 10 10 for PH 8.0-adjusted bacteria. It was ko/g. Example 2 In Example 1, Bifidobacterium concentrate (number of viable bacteria 1.5×10 11 /ml) was obtained. Meanwhile, a stabilizer solution containing 20% skim milk powder, 2% soluble starch, and 2% sodium glutamate was prepared. The pH of this solution was 6.6. Next, the pH of the stabilizer solution was adjusted to 9.0 with 15% potassium hydroxide solution.
ml, mixed and lyophilized as in Example. 55 g of dried bacterial cells with a drying loss of 1.60% and a viable bacterial count of 2×10 11 cells/g were obtained. The loss on drying of dried bacterial cells without pH adjustment was 1.50%, and the number of viable bacteria was 1.5×10 11 cells/g.
After filling 1 g of these dried bacterial cells into an aluminum laminate film and storing it at 45℃ for 1 month, the number of surviving bacteria is as follows:
1.5 x 108 cells/g for non-PH adjusted bacteria cells, 1.5 x 108 cells/g for PH 9.0 adjusted bacteria cells
It was 4.5×10 10 pieces/g.
Claims (1)
〜10に調整し、凍結乾燥することを特徴とするビ
フイズス乾燥菌体の安定化方法。1 The pH of the solution containing Bifidobacterium and stabilizer is 7.
A method for stabilizing dried Bifidus cells, which comprises adjusting the concentration to ~10 and freeze-drying.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59028225A JPS60172280A (en) | 1984-02-17 | 1984-02-17 | Method for stabilizing dried bacterial cell of bacteria belonging to genus bifidobacterium |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59028225A JPS60172280A (en) | 1984-02-17 | 1984-02-17 | Method for stabilizing dried bacterial cell of bacteria belonging to genus bifidobacterium |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS60172280A JPS60172280A (en) | 1985-09-05 |
JPH046349B2 true JPH046349B2 (en) | 1992-02-05 |
Family
ID=12242665
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP59028225A Granted JPS60172280A (en) | 1984-02-17 | 1984-02-17 | Method for stabilizing dried bacterial cell of bacteria belonging to genus bifidobacterium |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS60172280A (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3727946A1 (en) * | 1987-08-21 | 1989-03-02 | Werner Georg Munk | RECONSTITUTABLE DRY PRODUCT FOR DIRECT CONSUMPTION, METHOD FOR THE PRODUCTION THEREOF AND ITS USE |
JP4866842B2 (en) * | 2005-03-30 | 2012-02-01 | 協和発酵バイオ株式会社 | Method for improving storage stability of dried microorganisms |
JP7178203B2 (en) * | 2018-08-07 | 2022-11-25 | 株式会社ヤクルト本社 | Method for producing freeze-dried lactic acid bacteria |
-
1984
- 1984-02-17 JP JP59028225A patent/JPS60172280A/en active Granted
Non-Patent Citations (2)
Title |
---|
BERGEY S MANUAL OF DETERMINATIVE BACTERIOLOGY=1957 * |
BERGEY S MANUAL OF DETERMINATIVE BACTERIOLOGY=1974 * |
Also Published As
Publication number | Publication date |
---|---|
JPS60172280A (en) | 1985-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TAMURA | Nutriology of bifidobacteria | |
KR101605516B1 (en) | Method for Increasing Viability, Storage Stability, Acid Tolerance or Oxgall Tolerance of Lactic Acid Bacteria | |
EP0753303B1 (en) | Use of a physiologically functional food for improving and/or enhancing brain function, learning ability and memory functions | |
US4797290A (en) | Lyophilized process for the production of a kefir yoghurt | |
US4187321A (en) | Method for producing foods and drinks containing bifidobacteria | |
DK2647694T3 (en) | BIOMASS OF DEATH LACTOBACILLUS FOR ANTIMICROBIAL USE AND PROCEDURE FOR PREPARING THEREOF | |
EP0833644B1 (en) | Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders | |
US20100015285A1 (en) | Process of preparing direct-acidified milk beverage keeping high viable cell count at ambient temperature | |
CN113652359B (en) | Lactic acid bacteria freeze-dried powder, preparation method and freeze-dried protective agent thereof | |
JP2002320473A (en) | Method for producing doubly coated lactobacillus bulk powder utilizing protein and polysaccharide | |
KR102643788B1 (en) | Culture media for producing high yield of Akkermansia sp., culturing method and freeze drying method using it | |
JP3501415B2 (en) | Bifidobacterium and lactic acid bacteria growth promoter | |
JPH046349B2 (en) | ||
JP3017456B2 (en) | High-concentration culture method and culture product of propionic acid bacteria and processed product thereof | |
JP3761270B2 (en) | β-Fructofuranosidase, production method and use thereof | |
US20210317401A1 (en) | Use of cysteine or salt thereof for cryoprotecting lactic acid bacteria | |
CN114107104B (en) | Lactobacillus bulgaricus freeze-dried powder and preparation method thereof | |
CA1311204C (en) | Growth promoter for bifidobacterium species, process for preparing the same and method of using the same | |
JPS6316118B2 (en) | ||
JPS61108385A (en) | Production of bifidus baceterium powder | |
JP2004081206A (en) | Method for processing spirulina | |
JPS60188060A (en) | Live mold powder of bacterium belonging to genus bifidobacterium, having high resistance to acid in stomach, and its preparation | |
Yamazaki et al. | Measurement of growth of bifidobacteria on inulofructosaccharides | |
EP3524051A1 (en) | Matricial microencapsulation compositions | |
GB1582068A (en) | Powder composition comprising viable bifidobacteria cells containing powder and lactulose containing powder |